Сайт предназначен для врачей
Поиск:

 

Список литературы 

1.     Neulander E.Z., Soloway M.S. Failure after radicalprostatectomy. Urology. 2003; 61: 30-36.

2.     Freedland S.J., Sutter M.E., Dorey F., Aronson W.J.Defining the ideal cutpoint for determiningPSA recurrence  after radical  prostatectomy.Urology. 2003; 61: 365-369.

3.     Amling C.L., Bergstralh E J., Blute M.L., Slezak A.,Zincke H. Defining prostate specific antigen progression after radical prostatectomy: what is themost appropriate cutpoint? J.  Urol. 2001; 165:11-46.

4.     Neulander E.Z., Soloway M.S. Failure after radicalprostatectomy. Urology. 2003; 61: 30-36.

5.     Miralbell R., Vees H., Lozano J. et al. EndorectalMRI assessment of local relapse after surgery forprostate cancer: a model to define treatment field guidelines for adjuvant radiotherapy in patients at high risk for local failure. Int.J. Radiat. Oncol. ВЫ. Phys. 2007; 67:356-361.

6.     Hricak H., Schoder H., Pucar D. et al. Advances in imaging in the postoperative patient with a rising prostate-specific antigen level. Semin. Oncol. 2003; 30: 616-634.

 

7.     Amsellem-Ouazana D., Brunes P., Conquy S. et al. Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study. Eur. Urol. 2005; 47:582-586.

 

8.     Aus G., Abbou C.C., Bolla M. et al. EAU guidelines on prostate cancer. Eur. Urol. 2005; 48: 546-551.

 

 

ANGIOLOGIA.ru (АНГИОЛОГИЯ.ру) - портал о диагностике и лечении заболеваний сосудистой системы